Literature DB >> 1553339

Cutaneous metabolism of nitroglycerin in vitro. I. Homogenized versus intact skin.

N Higo1, R S Hinz, D T Lau, L Z Benet, R H Guy.   

Abstract

The metabolism of nitroglycerin (GTN) to 1,2- and 1,3-glyceryl dinitrate (GDN) by hairless mouse skin in vitro has been measured. In the first set of experiments, GTN was incubated with the 9000g supernatant of fresh, homogenized tissue in the presence and absence of glutathione (GSH), a cofactor for glutathione-S-transferase. After 2 hr of incubation with GSH, 30% of the initially present GTN had been converted to 1,2- and 1,3-GDN; without GSH, less than 5% of the GTN was metabolized. The ratio of 1,2-GDN to 1,3-GDN produced by the homogenate was 1.8-2.1. In the second series of studies, GTN was administered topically to freshly excised, intact hairless mouse skin in conventional in vitro diffusion cells. The concurrent transport and metabolism of GTN was then monitored by sequential analysis of the receptor phase perfusing the dermal side of the tissue. Three topical formulations were used: a low concentration (1 mg/ml) aqueous solution, a 2% ointment, and a transdermal delivery system. Delivery of total nitrates (GTN + 1,2-GDN + 1,3-GDN) into the receptor phase was similar for ointment and patch formulations and much greater than that from the solution. The percentage metabolites formed, however, was greatest for the solution (61% and 2 hr, compared to 49% for the patch and 35% for the ointment). As has been noted before, therefore, the relative level of skin metabolism is likely to be greatest when the transepidermal flux is small. Distinct from the homogenate experiments, the 1,2/1,3-GDN ratios in the penetration studies were in the range 0.7-0.9.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1553339     DOI: 10.1023/a:1018925004345

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  Skin structure and metabolism: relevance to the design of cutaneous therapeutics.

Authors:  D A Bucks
Journal:  Pharm Res       Date:  1984-07       Impact factor: 4.200

Review 2.  Transdermal drug delivery and cutaneous metabolism.

Authors:  R H Guy; J Hadgraft; D A Bucks
Journal:  Xenobiotica       Date:  1987-03       Impact factor: 1.908

3.  Malignant transformation of cells derived from mouse prostate by epoxides and other derivatives of polycyclic hydrocarbons.

Authors:  H Marquardt; T Kuroki; E Huberman; J K Selkirk; C Heidelberger; P L Grover; P Sims
Journal:  Cancer Res       Date:  1972-04       Impact factor: 12.701

4.  Nitroglycerin revisited: chemistry, biochemistry, interactions.

Authors:  F J di Carlo
Journal:  Drug Metab Rev       Date:  1975       Impact factor: 4.518

5.  Variable glyceryl dinitrate formation as a function of route of nitroglycerin administration.

Authors:  P K Noonan; L Z Benet
Journal:  Clin Pharmacol Ther       Date:  1987-09       Impact factor: 6.875

6.  Cutaneous metabolism of nitroglycerin in vitro. II. Effects of skin condition and penetration enhancement.

Authors:  N Higo; R S Hinz; D T Lau; L Z Benet; R H Guy
Journal:  Pharm Res       Date:  1992-03       Impact factor: 4.200

7.  Blood vessel uptake and metabolism of organic nitrates in the rat.

Authors:  H L Fung; S C Sutton; A Kamiya
Journal:  J Pharmacol Exp Ther       Date:  1984-02       Impact factor: 4.030

8.  Pharmacokinetics and bioavailability of intravenous and topical nitroglycerin in the rhesus monkey: estimate of percutaneous first-pass metabolism.

Authors:  R C Wester; P K Noonan; S Smeach; L Kosobud
Journal:  J Pharm Sci       Date:  1983-07       Impact factor: 3.534

9.  Simultaneous determination of nitroglycerin and its dinitrate metabolites by capillary gas chromatography with electron-capture detection.

Authors:  F W Lee; N Watari; J Rigod; L Z Benet
Journal:  J Chromatogr       Date:  1988-04-29

10.  Maintenance of skin viability during in vitro percutaneous absorption/metabolism studies.

Authors:  S W Collier; N M Sheikh; A Sakr; J L Lichtin; R F Stewart; R L Bronaugh
Journal:  Toxicol Appl Pharmacol       Date:  1989-07       Impact factor: 4.219

View more
  6 in total

1.  Selegiline percutaneous absorption in various species and metabolism by human skin.

Authors:  S Rohatagi; J S Barrett; L J McDonald; E M Morris; J Darnow; A R DiSanto
Journal:  Pharm Res       Date:  1997-01       Impact factor: 4.200

2.  Cutaneous metabolism of nitroglycerin in vitro. II. Effects of skin condition and penetration enhancement.

Authors:  N Higo; R S Hinz; D T Lau; L Z Benet; R H Guy
Journal:  Pharm Res       Date:  1992-03       Impact factor: 4.200

3.  Development of an on-animal separation-based sensor for monitoring drug metabolism in freely roaming sheep.

Authors:  David E Scott; Sean D Willis; Seth Gabbert; David Johnson; Erik Naylor; Elsa M Janle; Janice E Krichevsky; Craig E Lunte; Susan M Lunte
Journal:  Analyst       Date:  2015-06-07       Impact factor: 4.616

Review 4.  Organic nitrate metabolism and action: toward a unifying hypothesis and the future-a dedication to Professor Leslie Z. Benet.

Authors:  Nathaniel A Page; Ho-Leung Fung
Journal:  J Pharm Sci       Date:  2013-05-13       Impact factor: 3.534

5.  Percutaneous penetration kinetics of nitroglycerin and its dinitrate metabolites across hairless mouse skin in vitro.

Authors:  T Kikkoji; M Gumbleton; N Higo; R H Guy; L Z Benet
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

Review 6.  Xenobiotic bioconversion in human epidermis models.

Authors:  Audra L Stinchcomb
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.